fda drug shortages tirzepatide zepbound shortage status 2025 Compounders lose battle over Eli Lilly weight loss and list Lilly's weight-loss drug removed from

The news: The FDA this week issued 30 warning letters to telehealth companies selling compounded GLP-1 weight loss drugs over false or misleading marketing claims

In an interesting study Atp1a2 , the inhibitor of cysteine proteases Cst3 , the neural plasticity regulators neuroxexins ( Nrxn1/2 ), and the genes involved in GABA neurotransmitter metabolism such as the two GABA transporter mRNAs Slc6a11 and Slc6a1 and the GABA-A receptor subunit mRNA Gabrb1

This compounded version includes: Glycine, an amino acid known for its calming, anti-inflammatory, and detoxifying benefits

GLP-1 Success Story GLP-1 agonists (also called GLP-1RAs), and related drugs like dual agonists of gastric inhibitory polypeptide (GIP)/GLP-1, have revolutionized obesity treatment by demonstrating significant and sustained weight loss in clinical trials and real-world use